Healthcare  Name:  Sector:  Chief Executive: TolerRx Healthcare Doug Ringler, VMD  Summary: Biopharmaceutical company specializing in the discovery and development of therapies that induce and maintain immunological tolerance.  Stage of Initial  Investment: Seed/Early  Liquidity: Private 300 Technology Square, 4th Floor Cambridge, MA 02139 Phone: 617.354.8100 Fax: 617.354.8300
	Copyright ©2009 Rho Capital Partners, Inc.